Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets
$ in Millions, $ in Millions
Mar. 31, 2019
USD ($)
Mar. 31, 2018
USD ($)
Current assets:    
Cash and cash equivalents $ 78.7 $ 281.6
Restricted cash and cash equivalents 5.1 5.0
Restricted cash and cash equivalents - Asbestos 39.8 26.6
Restricted short-term investments - Asbestos 17.7 38.4
Accounts and other receivables, net of provision for doubtful trade debts of US$2.9 million and US$1.3 million as of 31 March 2019 and 31 March 2018 254.6 202.7
Inventories 317.4 255.7
Prepaid expenses and other current assets 31.3 25.4
Insurance receivable - Asbestos 7.5 5.1
Workers’ compensation - Asbestos 2.0 2.1
Total current assets 754.1 842.6
Property, plant and equipment, net 1,388.4 992.1
Goodwill 201.1 4.9
Intangible assets, net 174.4 12.3
Insurance receivable - Asbestos 43.7 52.8
Workers’ compensation - Asbestos 25.8 28.8
Deferred income taxes 1,092.9 29.9
Deferred income taxes - Asbestos 349.3 382.9
Other assets 2.9 4.7
Total assets 4,032.6 2,351.0
Current liabilities:    
Accounts payable and accrued liabilities 255.5 193.3
Accrued payroll and employee benefits 84.9 61.8
Accrued product warranties 6.8 7.3
Income taxes payable 13.4 3.2
Asbestos liability 110.5 114.1
Workers’ compensation - Asbestos 2.0 2.1
Other liabilities 9.9 12.8
Total current liabilities 483.0 394.6
Long-term debt 1,380.3 884.4
Deferred income taxes 80.4 66.4
Accrued product warranties 39.8 45.5
Income taxes payable 25.2 25.9
Asbestos liability 979.1 1,101.0
Workers’ compensation - Asbestos 25.8 28.8
Other liabilities 44.6 25.9
Total liabilities 3,058.2 2,572.5
Commitments and contingencies (Note 14)
Shareholders’ equity (deficit):    
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 442,269,905 shares issued and outstanding at 31 March 2019 and 441,524,118 shares issued and outstanding at 31 March 2018 230.0 229.5
Additional paid-in capital 197.6 185.6
Accumulated equity (deficit) 577.1 (635.3)
Accumulated other comprehensive loss (30.3) (1.3)
Total shareholders’ equity (deficit) 974.4 (221.5)
Total liabilities and shareholders’ equity (deficit) $ 4,032.6 $ 2,351.0